Edgewise Therapeutics, Inc. EWTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$49.01M-20.1% | -$50.22M-26.6% | -$40.67M-19.2% | -$36.12M-14.7% | -$40.8M-43.0% | ||
| $537K+4.7% | $525K-9.0% | $500K0.0% | $500K0.0% | $513K+8.5% | ||
| $8.72M-3.8% | $9.88M+27.6% | $8.09M+17.5% | $7.73M+48.0% | $9.06M+86.0% | ||
| -$42.54M-12.4% | -$38.59M-43.2% | -$34.78M-27.0% | -$32.58M-24.8% | -$37.87M-32.4% | ||
| $260K+491% | $73K-73.4% | $105K-79.8% | $34K-84.6% | $44K-85.2% | ||
| $2.43M-94.5% | —— | —— | -$162.17M— | $43.9M+116% | ||
| $12.17M+448% | $3.98M+37.3% | $1.66M-50.2% | $188.23M+9,543% | $2.22M-99.1% | ||
| -$27.94M-438% | $15.15M+582% | $2.6M— | —— | $8.26M+115% | ||
| -$42.8M-12.9% | -$38.67M-42.0% | -$34.88M-25.0% | -$32.62M-23.9% | -$37.91M-31.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Edgewise Therapeutics, Inc. generate?
- Edgewise Therapeutics, Inc. (EWTX) generated -$148.5M in operating cash flow over the trailing twelve months.
- What is Edgewise Therapeutics, Inc.'s free cash flow?
- After $472.0K of capital expenditures, Edgewise Therapeutics, Inc.'s free cash flow was -$149.0M over the trailing twelve months, down 24.8% year over year.
- Where does Edgewise Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Edgewise Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.